Mide Hastalıkları ve Helicobacter Pylori
Gastrit, reflü, peptik ülser ve Helicobacter pylori enfeksiyonu üzerine yayımlanmış çalışmalar.
15 публикаций
Gastroesophageal reflux in asymptomatic patients with diabetes: an impedance study diabetes, obesity and gastroesophageal reflux
S Gokturk, F Akyuz, S Arici, B Alpaslan, A Ormeci, OM Soyer, S Evirgen, ...
Experimental and Clinical Endocrinology & Diabetes 128 (01), 52-58 · 2020 · 21 atıf
Can Helicobacter pylori be eradicated with high-dose proton pump inhibitor in extensive metabolizers with the CYP2C19 genotypic polymorphism
A Ormeci, Z Emrence, B Baran, OM Soyer, S Gokturk, S Evirgen, F Akyuz, ...
Eur Rev Med Pharmacol Sci 20 (9), 1795-1797 · 2016 · 28 atıf
Does gastroesophageal reflux increase chronic obstructive pulmonary disease exacerbations?
S Iliaz, R Iliaz, ST Onur, S Arici, U Akyuz, C Karaca, K Demir, F Besisik, ...
Respiratory medicine 115, 20-25 · 2016 · 23 atıf
Effect of cytochrome P450 2C19 polymorphisms on the Helicobacter pylori eradication rate following two-week triple therapy with pantoprazole or rabeprazole.
A Ormeci, Z Emrence, B Baran, S Gokturk, OM Soyer, S Evirgen, F Akyuz, ...
European Review for Medical & Pharmacological Sciences 20 (5), 879 · 2016 · 21 atıf
The frequency of gastro-esophageal reflux disease in patients with mild-moderate stage chronic obstructive lung disease (COPD) and its relationship with acute exacerbations of COPD
S Iliaz, F Akyuz, ST Onur, U Akyuz, C Karaca, K Demir, F Besisik, ...
NEUROGASTROENTEROLOGY AND MOTILITY 27, 70-70 · 2015 · 1 atıf
Tu1103 is diabetes mellitus a risk factor for gastroesophageal reflux?
S Gokturk, F Besşsşk, S Arici, B Alpaslan, A Ormeci, OM Soyer, S Evirgen, ...
Gastroenterology 5 (146), S-753 · 2014 · 1 atıf
Effect of genotypic differences in CYP2C19 and on cure rates for Helicobacter pylori infection by triple therapy with different proton pump inhibitors
K Demir, A Ormeci, Z Emrence, S Gokturk, B Baran, OM Soyer, F Akyuz, ...
GASTROENTEROLOGY 144 (5), S333-S333 · 2013 · 1 atıf
Sa1915 Effect of Genotypic Differences in CYP2C19 and on Cure Rates for Helicobacter pylori Infection by Triple Therapy With Different Proton Pump Inhibitors
K Demir, A Ormeci, Z Emrence, S Gokturk, B Baran, OM Soyer, F Akyuz, ...
Gastroenterology 5 (144), S-333 · 2013
Distribution of gastric lymphoid follicles in Helicobacter pylori-associated gastritis.
M Sokmen, D Sakiz, N Akbayir, C Karaca, O Ersoy, C Alkim, H Demirsoy
Hepato-gastroenterology 54 (73), 285-289 · 2007 · 7 atıf
The Role of Gastric Helicobacter Pylori Infection in Laryngopharyngeal Reflux Disease
İI Ercan, BÖ Çakir, TÇ Uzel, D Sakiz, Ç Karaca, S Turgut
Otolaryngology—Head and Neck Surgery 135 (1), 52-55 · 2006 · 47 atıf
Pneumatic balloon dilatation in primary achalasia: the long-term follow-up results.
G Boztas, Z Mungan, S Ozdil, F Akyüz, C Karaca, K Demir, S Kaymakoglu, ...
Hepato-gastroenterology 52 (62), 475-480 · 2005 · 73 atıf
Dispepsili hastalarda midenin prekanseröz lezyonları ile karşılaşma riski
L Erdem, N Akbayır, D Sakız, C Alkım, HM Sökmen, Ç Karaca, N Polat
Akademik Gastroenteroloji Dergisi 4 (2), 78-82 · 2005 · 5 atıf
Is lower socio-economic status a risk factor for Helicobacter pylori infection in pregnant women with hyperemesis gravidarum?
C Karaca, N Güler, A Yazar, H Camlica, K Demir, G Yildirim
Turkish Journal of Gastroenterology 15 (2), 86-89 · 2004 · 65 atıf
The effect of pneumatic balloon dilatation on gastric emptying in patients with achalasia.
K Cetin, B Gungor, A Isik, D Ahmet, A Filiz, A Nevzat, O Sadakat, D Cengiz, ...
Hepato-gastroenterology 50, ccci-cccii · 2003
Benign Small Bowel Ulcers: What Is the Most Common Cause?
V Şenkal, B Çavuş, BP Şimşek, AÇ Örmeci, Ü Akyüz, ÖM Soyer, Ç Karaca, ...
Age 70 (135), 75.8